IBDEI31P ; ; 04-FEB-2020
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,48628,1,4,0)
 ;;=4^I69.923
 ;;^UTILITY(U,$J,358.3,48628,2)
 ;;=^5007556
 ;;^UTILITY(U,$J,358.3,48629,0)
 ;;=I69.952^^185^2424^26
 ;;^UTILITY(U,$J,358.3,48629,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,48629,1,3,0)
 ;;=3^Cerebrovascular Disease,Hemiplegia/Hemiparesis,Left Dominant Side
 ;;^UTILITY(U,$J,358.3,48629,1,4,0)
 ;;=4^I69.952
 ;;^UTILITY(U,$J,358.3,48629,2)
 ;;=^5133586
 ;;^UTILITY(U,$J,358.3,48630,0)
 ;;=I69.954^^185^2424^27
 ;;^UTILITY(U,$J,358.3,48630,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,48630,1,3,0)
 ;;=3^Cerebrovascular Disease,Hemiplegia/Hemiparesis,Left Nondominant Side
 ;;^UTILITY(U,$J,358.3,48630,1,4,0)
 ;;=4^I69.954
 ;;^UTILITY(U,$J,358.3,48630,2)
 ;;=^5133587
 ;;^UTILITY(U,$J,358.3,48631,0)
 ;;=I69.951^^185^2424^28
 ;;^UTILITY(U,$J,358.3,48631,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,48631,1,3,0)
 ;;=3^Cerebrovascular Disease,Hemiplegia/Hemiparesis,Right Dominant Side
 ;;^UTILITY(U,$J,358.3,48631,1,4,0)
 ;;=4^I69.951
 ;;^UTILITY(U,$J,358.3,48631,2)
 ;;=^5007561
 ;;^UTILITY(U,$J,358.3,48632,0)
 ;;=I69.953^^185^2424^29
 ;;^UTILITY(U,$J,358.3,48632,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,48632,1,3,0)
 ;;=3^Cerebrovascular Disease,Hemiplegia/Hemiparesis,Right Nondominant Side
 ;;^UTILITY(U,$J,358.3,48632,1,4,0)
 ;;=4^I69.953
 ;;^UTILITY(U,$J,358.3,48632,2)
 ;;=^5007562
 ;;^UTILITY(U,$J,358.3,48633,0)
 ;;=I69.942^^185^2424^30
 ;;^UTILITY(U,$J,358.3,48633,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,48633,1,3,0)
 ;;=3^Cerebrovascular Disease,Monoplegia,Lt Lower Dominant Side
 ;;^UTILITY(U,$J,358.3,48633,1,4,0)
 ;;=4^I69.942
 ;;^UTILITY(U,$J,358.3,48633,2)
 ;;=^5133582
 ;;^UTILITY(U,$J,358.3,48634,0)
 ;;=I69.944^^185^2424^31
 ;;^UTILITY(U,$J,358.3,48634,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,48634,1,3,0)
 ;;=3^Cerebrovascular Disease,Monoplegia,Lt Lower Nondominant Side
 ;;^UTILITY(U,$J,358.3,48634,1,4,0)
 ;;=4^I69.944
 ;;^UTILITY(U,$J,358.3,48634,2)
 ;;=^5133585
 ;;^UTILITY(U,$J,358.3,48635,0)
 ;;=I69.932^^185^2424^32
 ;;^UTILITY(U,$J,358.3,48635,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,48635,1,3,0)
 ;;=3^Cerebrovascular Disease,Monoplegia,Lt Upper Dominant Side
 ;;^UTILITY(U,$J,358.3,48635,1,4,0)
 ;;=4^I69.932
 ;;^UTILITY(U,$J,358.3,48635,2)
 ;;=^5133580
 ;;^UTILITY(U,$J,358.3,48636,0)
 ;;=I69.934^^185^2424^33
 ;;^UTILITY(U,$J,358.3,48636,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,48636,1,3,0)
 ;;=3^Cerebrovascular Disease,Monoplegia,Lt Upper Nondominant Side
 ;;^UTILITY(U,$J,358.3,48636,1,4,0)
 ;;=4^I69.934
 ;;^UTILITY(U,$J,358.3,48636,2)
 ;;=^5133583
 ;;^UTILITY(U,$J,358.3,48637,0)
 ;;=I69.941^^185^2424^34
 ;;^UTILITY(U,$J,358.3,48637,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,48637,1,3,0)
 ;;=3^Cerebrovascular Disease,Monoplegia,Rt Lower Dominant Side
 ;;^UTILITY(U,$J,358.3,48637,1,4,0)
 ;;=4^I69.941
 ;;^UTILITY(U,$J,358.3,48637,2)
 ;;=^5133581
 ;;^UTILITY(U,$J,358.3,48638,0)
 ;;=I69.943^^185^2424^35
 ;;^UTILITY(U,$J,358.3,48638,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,48638,1,3,0)
 ;;=3^Cerebrovascular Disease,Monoplegia,Rt Nondominant Side
 ;;^UTILITY(U,$J,358.3,48638,1,4,0)
 ;;=4^I69.943
 ;;^UTILITY(U,$J,358.3,48638,2)
 ;;=^5133584
 ;;^UTILITY(U,$J,358.3,48639,0)
 ;;=I69.931^^185^2424^36
 ;;^UTILITY(U,$J,358.3,48639,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,48639,1,3,0)
 ;;=3^Cerebrovascular Disease,Monoplegia,Rt Upper Dominant Side
